中华老年心脑血管病杂志

[1] Tritschler T,Aujesky D.Venous thromboembolism in the elderly:a narrative review[J].Thromb Res,2017,155:140-147.DOI:10.1016/j.thromres.2017.05.015.

[2] Mismetti P,Bertoletti L,Gouin I,et al.Elderly patients with venous thromboembolism:insights from the RIETE registry[J].Presse Med,2024,53(4):104246.DOI:10.1016/j.lpm.2024.104246.

[3] Zhai Z,Kan Q,Li W,et al.VTE risk profiles and prophylaxis in medical and surgical inpatients:the identification of Chinese hospitalized patients' risk profile for venous thromboembolism (DissolVE-2)—a cross-sectional study[J].Chest,2019,155(1):114-122.DOI:10.1016/j.chest.2018.09.020.

[4] Cao J,Li S,Ma Y,et al.Risk factors associated with deep venous thrombosis in patients with different bed-rest durations:a multi-institutional case-control study[J].Int J Nurs Stud,2021,114:103825.DOI:10.1016/j.ijnurstu.2020.103825.

[5] Lind MM,Johansson M,Sj?lander A,et al.Incidence and risk factors of venous thromboembolism in men and women[J].Thromb Res,2022,214:82-86.DOI:10.1016/j.thromres.2022.04.014.

[6] Heit JA.Epidemiology of venous thromboembolism[J].Nat Rev Cardiol,2015,12(8):464-74.DOI:10.1038/nrcardio.2015.83

[7] Kabashneh S,Singh V,Alkassis S.A comprehensive literature review on the management of distal deep vein thrombosis[J].Cureus,2020,12(5):e8048.DOI:10.7759/cureus.8048.

[8] Bakhsh E.The benefits and imperative of venous thromboembolism risk screening for hospitalized patients:a systematic review[J].J Clin Med,2023,12(22):7009.DOI:10.3390/jcm12227009.

[9] Arakaki D,Iwata M,Terasawa T.External validation and update of the international medical prevention registry on venous thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients:a retrospective single-center cohort study in Japan[J].Thromb J,2024,22(1):31.DOI:10.1186/s12959-024-00603-w.

[10] Rahaghi FN,Minhas JK,Heresi GA.Diagnosis of deep venous thrombosis and pulmonary embolism:new imaging tools and modalities[J].Clin Chest Med,2018,39(3):493-504.DOI:10.1016/j.ccm.2018.04.003.

[11] Abdelaal Ahmed Mahmoud M Alkhatip A,Donnelly M,Snyman L,et al.YEARS algorithm versus Wells' score:predictive accuracies in pulmonary embolism based on the gold standard CT pulmonary angiography[J].Crit Care Med,2020,48(5):704-708.DOI:10.1097/CCM.0000000000004271.

[12] Essat M,Goodacre S,Pandor A,et al.Diagnostic accuracy of D-dimer for acute aortic syndromes:systematic review and meta-analysis[J].Ann Emerg Med,2024,84(4):409-421.DOI:10.1016/j.annemergmed.2024.05.001.

[13] Barrett L,Jones T,Horner D.The application of an age adjusted D-dimer threshold to rule out suspected venous thromboembolism (VTE) in an emergency department setting:a retrospective diagnostic cohort study[J].BMC Emerg Med,2022,22(1):186.DOI:10.1186/s12873-022-00736-z.

[14] Greenall R.Prevention,diagnosis and treatment of venous thromboembolism[J].Nurs Older People,2017,29(1):21-25.DOI:10.7748/nop.2017.e872.

[15] Fu Q,Liu DX,Kong XC,et al.Combined MR imaging for pulmonary embolism and deep venous thrombosis by contrast-enhanced MR volume interpolated body examination[J].Curr Med Sci,2020,40(1):192-198.DOI:10.1007/s11596-020-2164-6.

[16] Hu X,Ma L,Zhang J,et al.Use of pulmonary CT angiography with low tube voltage and low-iodine-concentration contrast agent to diagnose pulmonary embolism[J].Sci Rep,2017,7(1):12741.DOI:10.1038/s41598-017-13077-w.

[17] Palm V,Rengier F,Rajiah P,et al.Acute pulmonary embolism:imaging techniques,findings,endovascular treatment and differential diagnoses[J].Rofo,2020,192(1):38-49.DOI:10.1055/a-0900-4200.

[18] Chopard R,Albertsen IE,Piazza G.Diagnosis and treatment of lower extremity venous thromboembolism:a review[J].JAMA,2020,324(17):1765-1776.DOI:10.1001/jama.2020.17272.

[19] 亓志玲，丁德涛，吴翠环，等.ICU脓毒症患者早期发生下肢深静脉血栓预测模型的构建与验证[J].中华危重病急救医学，2024,36(5):471-477.DOI:10.3760/cma.j.cn121430-20231117-00985.

[20] Stevens SM,Woller SC,Kreuziger LB,et al.Antithrombotic therapy for VTE disease:second update of the CHEST guideline and expert panel report[J].Chest,2021,160(6):e545-e608.DOI:10.1016/j.chest.2021.07.055.

[21] Kakkos S,Kirkilesis G,Caprini JA,et al.Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism[J].Cochrane Database Syst Rev,2022,1(1):CD005258.DOI:10.1002/14651858.CD005258.pub4.

[22] Partridge JA,Anton PM,Wallace JP,et al.Exercise social support,barriers,and instructions in venous thromboembolism survivors:a descriptive study[J].Res Pract Thromb Haemost,2023,7(5):102147.DOI:10.1016/j.rpth.2023.102147.

[23] Shi J,Weng X,Liu C,et al.The effect of the Ankle Pump Exercise (APE) counter system assisted ankle pump motion in patients after femoral neck fracture[J].BMC Musculoskelet Disord,2023,24(1):925.DOI:10.1186/s12891-023-06869-x.

[24] Tsuda K,Takahira N,Ejiri M,et al.Effect of resistance of the exercise band on the peak femoral vein velocity during active ankle flexion[J].Phlebology,2020,35(3):176-183.DOI:10.1177/0268355519865164.

[25] Duffett L.Deep venous thrombosis[J].Ann Intern Med,2022,175(9):ITC129-ITC144.DOI:10.7326/AITC202209200.

[26] Khatri A,Davies AH,Shalhoub J.Mechanical prophylaxis for venous thromboembolism prevention in obese individuals[J].Phlebology,2021,36(10):768-770.DOI:10.1177/02683 555211031147.

[27] Lafaie L,Poenou G,Hanon O,et al.Anticoagulation and venous thromboembolism in patients aged 90 years and older:Data from the RIETE registry[J].J Am Geriatr Soc,2024,72(1):113-125.DOI:10.1111/jgs.18626.

[28] Pess?a RL,Kessler VG,Becker GG,et al.Efficacy and safety of direct oral anticoagulants for acute treatment of venous thromboembolism in older adults:a network meta-analysis of randomised controlled trials[J].Vasc Endovascular Surg,2024,58(6):633-639.DOI:10.1177/15385744241253201.

[29] Lehto M,Luojus A,Halminen O,et al.Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation:a Nationwide Cohort Study[J].Ann Med,2024,56(1):2364825.DOI:10.1080/07853890.2024.2364825.

[30] Yang HQ,Liu MC,Yin WJ,et al.Safety and efficacy of low molecular weight heparin for thromboprophylaxis in the elderly:a network meta-analysis of randomized clinical trials[J].Front Pharmacol,2021,12:783104.DOI:10.3389/fphar.2021.783104.

[31] Akashi S,Oguri M,Ikeno E,et al.Outcomes and safety of very-low-dose edoxaban in frail patients with atrial fibrillation in the ELDERCARE-AF randomized clinical trial[J].JAMA Netw Open,2022,5(8):e2228500.DOI:10.1001/jamanetworkopen.2022.28500.

[32] Poli D,Antonucci E,Bertù L,et al.Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs:results from the prospective multicenter START2-register study[J].Thromb Res,2019,183:28-32.DOI:10.1016/j.thromres.2019.08.024.

[33] Carlin S,Cuker A,Gatt A,et al.Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis:guidance from the SSC of the ISTH[J].J Thromb Haemost,2024,22(9):2653-2669.DOI:10.1016/j.jtha.2024.05.023.

[34] Candeloro M,Carlin S,Shapiro MJ,et al.Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes:a systematic review[J].Res Pract Thromb Haemost,2023,7(3):100137.DOI:10.1016/j.rpth.2023.100137.

[35] Mazzolai L,Ageno W,Alatri A,et al.Second consensus document on diagnosis and management of acute deep vein thrombosis:updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function[J].Eur J Prev Cardiol,2022,29(8):1248-1263.DOI:10.1093/eurjpc/zwab088.

[36] Marti C,John G,Konstantinides S,et al.Systemic thrombolytic therapy for acute pulmonary embolism:a systematic review and meta-analysis[J].Eur Heart J,2015,36(10):605-614.DOI:10.1093/eurheartj/ehu218.

[37] Kaplovitch E,Shaw JR,Douketis J.Thrombolysis in pulmonary embolism:an evidence-based approach to treating life-threatening pulmonary emboli[J].Crit Care Clin,2020,36(3):465-480.DOI:10.1016/j.ccc.2020.02.004.

[38] 《中国血栓性疾病防治指南》专家委员会.中国血栓性疾病防治指南[J].中华医学杂志，2018,98(36):2861-2888.DOI:10.3760/cma.j.issn.0376-2491.2018.36.002.

[39] Takase T,Iwanaga Y,Yamashita Y,et al.Long-term effects of non-retrieved inferior vena cava filters on recurrences of venous thromboembolism in cancer and non-cancer patients:from the COMMAND VTE registry[J].Eur J Intern Med,2020,82:90-96.DOI:10.1016/j.ejim.2020.09.002.

[40] Duffett L,Carrier M.Inferior vena cava filters[J].J Thromb Haemost,2017,15(1):3-12.DOI:10.1111/jth.13564.

[41] 中国微循环学会周围血管疾病专业委员会压力学组.血管压力治疗中国专家共识(2021版)[J].中华医学杂志，2021,101(17):1214-1225.DOI:10.3760/cma.j.cn112137-20201111-03062.

[42] Schrag D,Uno H,Rosovsky R,et al.Direct oral anticoagulants vs low-molecular-weight heparin and recurrent VTE in patients with cancer:a randomized clinical trial[J].JAMA,2023,329(22):1924-1933.DOI:10.1001/jama.2023.7843.

[43] 付荣凤，薛峰.2022 ITAC国际临床实践指南：癌症(包括合并新冠肺炎患者)相关静脉血栓栓塞症的治疗和预防解读[J].血栓与止血学，2023,29(2):57-66.DOI:10.3969/j.issn.1009-6213.2023.02.001.

[44] Vlazny DT,Pasha AK,Kuczmik W,et al.Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosis[J].J Thromb Haemost,2021,19(9):2206-2215.DOI:10.1111/jth.15416.

[45] 李明霞，向秋芬，符琰，等.经外周静脉置入中心静脉导管相关性静脉血栓防治体系的构建与应用[J].广西医学，2020,42(6):776-778,785.DOI:10.11675/j.issn.0253-4304.2020.06.29.

[46] 国际血管联盟中国分会，中国老年医学学会周围血管疾病管理分会.输液导管相关静脉血栓形成防治中国专家共识(2020版)[J].中国实用外科杂志，2020,40(4):377-383.DOI:10.19538/j.cjps.issn1005-2208.2020.04.03.

[47] 亚洲急危重症协会中国腹腔重症协作组.重症患者中心静脉导管管理中国专家共识(2022版)[J].中华消化外科杂志，2022,21(3):313-322.DOI:10.3760/cma.j.cn115610-20220208-00068.

[48] 中华医学会骨科学分会创伤骨科学组，中华医学会骨科学分会外固定与肢体重建学组，中国医师协会骨科医师分会创伤专家工作委员会，等.中国创伤骨科患者围手术期静脉血栓栓塞症预防指南(2021)[J].中华创伤骨科杂志，2021,23(3):185-192.DOI:10.3760/cma.j.cn115530-20201228-00 795.

[49] Ng JY,D'Souza M,Hutani F,et al.Management of heparin-induced thrombocytopenia:a contemporary review[J].J Clin Med,2024,13(16):4686.DOI:10.3390/jcm13164686.

[50] Marron RM,Rali P,Hountras P,et al.Inferior vena cava filters:past,present,and future[J].Chest,2020,158(6):2579-2589.DOI:10.1016/j.chest.2020.08.002.